NCT05059184View on ClinicalTrials.gov

Long-term Sequelae of COVID-19 (Myalgic Encephalomyelitis): An International Cross-Sectional Study

CompletedOBSERVATIONAL
Enrollment

2,450

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

July 1, 2022

Study Completion Date

September 1, 2022

Conditions
Myalgic Encephalomyelitis
Interventions
OTHER

This is an observational cross-sectional study, there is no need for intervention

This is an observational cross-sectional study. There is no need for intervention

Trial Locations (1)

21523

Alexandria Faculty of Medicine, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER

NCT05059184 - Long-term Sequelae of COVID-19 (Myalgic Encephalomyelitis): An International Cross-Sectional Study | Biotech Hunter | Biotech Hunter